EnergyPathways PLC (AIM:EPP) has launched Front End Engineering and Design for what could become the world's largest compressed air energy storage project. Pre-FEED work with Siemens Energy confirmed the project's viability, with a £15 million financing package now in place to fund the next phase.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) has secured FDA Fast Track Designation for its lead cancer drug iSCIB1+ in advanced melanoma. Phase II trial data shows 77% progression-free survival at 20 months, compared with 43% for the current standard of care.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) is advancing partnering talks as interim data from its TOPICAL trial approaches this summer. The company estimates the addressable market for POLB 001 at more than $10 billion, with partner interest increasing as data nears.
Santhera Pharmaceuticals (SIX:SANN, OTC:SPHDF, FRA:S3F0) reported revenues up 97% to CHF 77.2 million, well ahead of guidance, driven by strong sales of its Duchenne muscular dystrophy drug AGAMREE. The company expects to reach cash flow breakeven in Q3 2026 without further fundraising.
Powerhouse Energy Group PLC (AIM:PHE, FRA:BT81) has won a £260,000 contract with a Welsh battery developer, its first revenue outside its Engsolve engineering arm. The company currently has around ten live enquiries it believes could become revenue-generating projects.
Active Energy Group PLC (AIM:AEG, OTCID:AEUSF) says its 8MVA site in the United Arab Emirates will become the first pilot deployment under its proposed Bitdeer collaboration. The site could generate around $300,000 per MVA in annual infrastructure revenue alongside 8.3 Bitcoin per MVA per year.
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.
